Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Liabilities: 2022-2024

Historic Total Liabilities for Gossamer Bio (GOSS) over the last 3 years, with Dec 2024 value amounting to $285.8 million.

  • Gossamer Bio's Total Liabilities fell 1.88% to $291.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $291.2 million, marking a year-over-year decrease of 1.88%. This contributed to the annual value of $285.8 million for FY2024, which is 14.71% up from last year.
  • Latest data reveals that Gossamer Bio reported Total Liabilities of $285.8 million as of FY2024, which was up 14.71% from $249.1 million recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Total Liabilities peaked at $285.8 million during FY2024, and registered a low of $249.1 million during FY2023.
  • Over the past 3 years, Gossamer Bio's median Total Liabilities value was $260.4 million (recorded in 2022), while the average stood at $265.1 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first declined by 4.31% in 2023, then increased by 14.71% in 2024.
  • Gossamer Bio's Total Liabilities (Yearly) stood at $260.4 million in 2022, then dropped by 4.31% to $249.1 million in 2023, then rose by 14.71% to $285.8 million in 2024.